DK103891A - Intralaesional behandling af pladeepitelcarcinoma med rekombinant human alfainterferon - Google Patents

Intralaesional behandling af pladeepitelcarcinoma med rekombinant human alfainterferon Download PDF

Info

Publication number
DK103891A
DK103891A DK103891A DK103891A DK103891A DK 103891 A DK103891 A DK 103891A DK 103891 A DK103891 A DK 103891A DK 103891 A DK103891 A DK 103891A DK 103891 A DK103891 A DK 103891A
Authority
DK
Denmark
Prior art keywords
recombinant human
carcinoma
pladeepetal
intralaesional
alfainterferon
Prior art date
Application number
DK103891A
Other languages
English (en)
Other versions
DK103891D0 (da
Inventor
Daniel J Tanner
Edwin A Peets
Kenneth A Smiles
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of DK103891A publication Critical patent/DK103891A/da
Publication of DK103891D0 publication Critical patent/DK103891D0/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK911038A 1988-12-01 1991-05-31 Intralaesional behandling af pladeepitelcarcinoma med rekombinant human alfainterferon DK103891D0 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27831588A 1988-12-01 1988-12-01
PCT/US1989/005287 WO1990006135A1 (en) 1988-12-01 1989-11-29 Treatment of squamous cell carcinoma intralesionally with recombinant human alpha interferon

Publications (2)

Publication Number Publication Date
DK103891A true DK103891A (da) 1991-05-31
DK103891D0 DK103891D0 (da) 1991-05-31

Family

ID=23064525

Family Applications (1)

Application Number Title Priority Date Filing Date
DK911038A DK103891D0 (da) 1988-12-01 1991-05-31 Intralaesional behandling af pladeepitelcarcinoma med rekombinant human alfainterferon

Country Status (14)

Country Link
EP (2) EP0446279A1 (da)
JP (1) JPH0647556B2 (da)
KR (1) KR950011889B1 (da)
AT (1) ATE92333T1 (da)
AU (1) AU634511B2 (da)
CA (1) CA2004202C (da)
DE (1) DE68908119T2 (da)
DK (1) DK103891D0 (da)
ES (1) ES2058555T3 (da)
IE (1) IE63121B1 (da)
IL (1) IL92495A (da)
MY (1) MY107071A (da)
WO (1) WO1990006135A1 (da)
ZA (1) ZA899113B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0563177A1 (en) * 1990-12-14 1993-10-06 Schering Corporation Oral administration of alpha interferon to treat lung malignancies
WO1992011025A2 (en) * 1990-12-21 1992-07-09 Schering Corporation Administering alpha interferon by oral inhalation to treat asthma and non-malignant proliferative pulmonary diseases
DE69625373T2 (de) * 1995-10-04 2003-05-15 Schering Corp Kombination von temozolomide und alpha-interferon zur behandlung von fortgeschrittenem krebs
US7294332B2 (en) 1995-10-04 2007-11-13 Schering Corporation Combination therapy (temozolomide and α-IFN) for advanced cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3278234D1 (en) * 1981-10-13 1988-04-21 Exovir Inc Interferon-containing compositions and the use of these compositions in the treatment of herpetic infections, pre-malignant skin lesions, skin malignancies and psoriasis
ZA873743B (en) * 1986-05-27 1987-11-25 Schering Corporation Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon

Also Published As

Publication number Publication date
EP0372809A1 (en) 1990-06-13
EP0372809B1 (en) 1993-08-04
KR900701311A (ko) 1990-12-01
KR950011889B1 (ko) 1995-10-12
DE68908119D1 (de) 1993-09-09
DE68908119T2 (de) 1993-11-18
JPH04500678A (ja) 1992-02-06
IL92495A0 (en) 1990-08-31
JPH0647556B2 (ja) 1994-06-22
IL92495A (en) 1995-05-26
IE893828L (en) 1990-06-01
ES2058555T3 (es) 1994-11-01
ZA899113B (en) 1990-08-29
MY107071A (en) 1995-09-30
ATE92333T1 (de) 1993-08-15
IE63121B1 (en) 1995-03-22
DK103891D0 (da) 1991-05-31
WO1990006135A1 (en) 1990-06-14
CA2004202A1 (en) 1990-06-01
AU634511B2 (en) 1993-02-25
EP0446279A1 (en) 1991-09-18
CA2004202C (en) 2001-02-13
AU4802590A (en) 1990-06-26

Similar Documents

Publication Publication Date Title
DK486588A (da) Konjungater af cytokininer med immunglobuliner
NO176665C (no) Fremgangsmåte for fremstilling av ikke-glykosylert IL-6 og vektor for utskillelse derav
DK0652966T3 (da) Fremgangsmåde til forøgelse af ekspression af virale proteiner
DK103891A (da) Intralaesional behandling af pladeepitelcarcinoma med rekombinant human alfainterferon
DK50987A (da) Polypeptid med plasminogenaktivatorvirkning
ES2036526T3 (es) Composiciones de interferon.
DK0382381T3 (da) Behandling af leukocyt-dysfunktion med GM-CSF
DK31386D0 (da) Behandling af proliferative hudsygdomme
ZA873743B (en) Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon
DK328088D0 (da) Farmaceutisk komposition til behandling af tumorer
EP0276120A3 (en) Treatment of certain leukemias with a combination of gamma interferon and alpha interferon
OA08768A (fr) Traitement du virus su SIDA par l'interféron alpha humain recombinant.
DE3750248T2 (de) Zubereitung und Behandlung der Haut mit Human-Leukocyten-Interferon.
KR870700350A (ko) 간염의 치료방법
DK527287D0 (da) Polypeptid med interleukin-2-aktiviteter
DK0381584T3 (da) Anvendelse af visse gamma-interferoner til behandling af ovariecancer
ATE54941T1 (de) Cystein verminderte muteine von biologisch aktiven menschlichen tnf-proteinen.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment